Page last updated: 2024-10-28

ibudilast and Cardiotoxicity

ibudilast has been researched along with Cardiotoxicity in 1 studies

Cardiotoxicity: Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nishiyama, K1
Numaga-Tomita, T1
Fujimoto, Y1
Tanaka, T1
Toyama, C1
Nishimura, A1
Yamashita, T1
Matsunaga, N1
Koyanagi, S1
Azuma, YT1
Ibuki, Y1
Uchida, K1
Ohdo, S1
Nishida, M1

Other Studies

1 other study available for ibudilast and Cardiotoxicity

ArticleYear
Ibudilast attenuates doxorubicin-induced cytotoxicity by suppressing formation of TRPC3 channel and NADPH oxidase 2 protein complexes.
    British journal of pharmacology, 2019, Volume: 176, Issue:18

    Topics: Animals; Antineoplastic Agents; Cardiotoxicity; Cell Line; Cell Survival; Doxorubicin; Humans; Male;

2019
chemdatabank.com